The Stowers Institute for Medical Research has opened a commercial arm, BioMed Valley Discoveries, whose goal is to produce cures or biomedical advancements that can be used for new drugs, research or startup companies, the Kansas City Star reports.
“Our focus is on translating basic biomedical discoveries into applications that will improve human health,” said David Chao, president and chief executive officer of BioMed Valley Discoveries. Chao previously headed licensing and research agreements at the Novartis Institutes of Biomedical Research.
The staff of Money Management Executive ("MME") has prepared these capsule summaries based on reports published by the news sources to which they are attributed. Those news sources are not associated with MME, and have not prepared, sponsored, endorsed, or approved these summaries.